Comments

ADMA Biologics

Q: What sector and industry does ADMA Biologics (ADMA) operate in?

ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ADMANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$17.40

-0.50-2.79%

At close: -

$17.40

0.000.00%

After Hours: Dec 20, 5:08 PM EDT

ADMA Biologics (ADMA) Forecast

News Earnings ADMA Biologics (ADMA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

ADMA Biologics (NASDAQ:ADMA) Stock Quotes, Forecast and News Summary

ADMA Biologics Stock (NASDAQ: ADMA) stock price, news, charts, stock research, profile.

Open	$17.16
Close	$17.40
Volume / Avg.	6.94M / 4.59M
Day Range	$17.08 - $17.96
52 Wk Range	4.06 - 23.64
Market Cap	$4.11B
P/E Ratio	66.30
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	5.62%
Days to Cover	5.14

Recent News

Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday

Avi Kapoor

CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter

Avi Kapoor

AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline

AstraZeneca (NASDAQ: AZN) announced that it has signed an exclusive license agreement with China-based CSPC Pharmaceutical Group Ltd for developing an early-stage, small molecule Lipoprotein (a) (Lp(a)) disruptor for helping patients with dyslipidaemia.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.16
Close	$17.40
Volume / Avg.	6.94M / 4.59M
Day Range	$17.08 - $17.96
52 Wk Range	4.06 - 23.64
Market Cap	$4.11B
P/E Ratio	66.30
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	5.62%
Days to Cover	5.14

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ADMA Biologics (ADMA) stock?

You can purchase shares of ADMA Biologics (NASDAQ:ADMA) through any online brokerage.

View our list of the best stock brokerages

Who are ADMA Biologics (ADMA) competitors?

Other companies in ADMA Biologics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for ADMA Biologics (ADMA) stock?

ADMA Biologics has a consensus price target of $21.25.

What is the current price for ADMA Biologics (ADMA)?

The stock price for ADMA Biologics (NASDAQ: ADMA) is $17.4 last updated December 20, 2024 at 5:08 PM EST.

Does ADMA Biologics (ADMA) pay a dividend?

There are no upcoming dividends for ADMA Biologics.

When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?

ADMA Biologics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is ADMA Biologics (ADMA) going to split?

There is no upcoming split for ADMA Biologics.

What sector and industry does ADMA Biologics (ADMA) operate in?

ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.